Table 3.

RV and LV Echocardiographic Indices at Baseline and Follow-Up

	Baseline			Follow-Up
Variable	No Adverse Events (n=29)	With Adverse Events (n=36)	P	No Adverse Events (n=28)	With Adverse Events (n= 34)	P
RVPSS, %	–15±4	–14±5	0.57	–17±4	–13.5±5	0.02
RVFAC, %	31±8	30±8	0.5	32±8	29±7	0.75
TAPSE, mm	14±4	14±4	0.9	15±4	14±5	0.6
RV-Sa, cm/s	10±4	10±4	0.46	11±4	10±3	0.86
RV-MPI	0.9	1.07	0.1	1.03	1.02	0.94
LVPSS, %	–6.9±2.5	–5.9±2.7	0.15	–7.5±2.3	–6.9±3.4	0.44

Data are presented as mean±SD.